> For the complete documentation index, see [llms.txt](https://guides.advertising.webtoon.com/llms.txt). Markdown versions of documentation pages are available by appending `.md` to page URLs; this page is available as [Markdown](https://guides.advertising.webtoon.com/ad-policies/guidelines-by-industry.md).

# Guidelines by Industry

This Guide applies together with the ‘Advertising Common Guidelines’. The Common Guidelines are the minimum standard, and this Industry-Specific Guide adds to and strengthens them. Where standards conflict on the same matter, the stricter standard prevails (see Application Principle 0 of the Common Guidelines).

※ \[Personal-information enhancement] The standards on prohibiting unauthorized collection of behavioral information through ad tags/SDKs, etc., and prohibiting forced redirection (hijacking ads), follow Sections 1.10 (Personal Information/Data Processing) and 1.8.1 of the Common Guidelines.

\* Industries and products that run counter to a sound media environment, such as loans, gambling/speculative activities, and tobacco, may not be run regardless of country even where permitted under local laws, and no country-specific exceptions are made (Common 0. Application Principles and 2.6.3). For other industries and products, eligibility to run is determined in line with each country's local laws; where a clause specifies the applicable country, that scope applies.

{% tabs %}
{% tab title="NAVER WEBTOON / LINE WEBTOON Industry-Specific Advertising Guide" %}

### **1.1 Food Advertising** <a href="#naverwebtoon-linewebtoonindustryspecificadvertisingguide-1.1foodadvertising" id="naverwebtoon-linewebtoonindustryspecificadvertisingguide-1.1foodadvertising"></a>

1.1.1 Content supporting the general maintenance of bodily functions or a healthy bodily condition may be advertised within the scope supported by objective evidence.

* However, such expressions must not imply medical efficacy or be structured to connect with disease treatment.
* Advertising content exceeding the scope of the product label is prohibited.

1.1.2 Content claiming efficacy in treating disease, or content likely to be confused with a pharmaceutical, may not be advertised.

* Expressions that directly mention the treatment/prevention/alleviation of disease are prohibited.
* Expressions that may cause food to be mistaken as having efficacy similar to a pharmaceutical are prohibited.
* Expressions that definitively assert health effects without medical basis are prohibited.

1.1.3 Using letters of appreciation/awards/testimonials, or content such as ‘flood of orders’/‘group endorsements’ and the like, may not be advertised.

* Expressions implying letters of appreciation, awards, testimonials (reviews), or endorsements by medical professionals or specific organizations/institutions are prohibited.
* Exaggerated expressions not based on fact, such as ‘almost sold out’, ‘flood of orders’, or ‘explosive popularity’, are prohibited.
* Content made to appear as an official certification or guarantee by a government/public agency.

1.1.4 Where a corrective order from the government or a relevant department has been issued, advertising is not permitted.

* Where any sanction, corrective order, sales restriction, recall directive, etc. concerning the product or advertisement has occurred in any country—such as the U.S. (FDA/FTC), the EU (EFSA), China (SAMR), Australia (TGA/ACCC), Indonesia (BPOM), or Thailand (Thai FDA)—advertising on that country’s page or on the global page may be restricted.
* In Japan, exaggerated advertising that misleads as to the efficacy/effects of food is strictly restricted under the Health Promotion Act and the Act against Unjustifiable Premiums and Misleading Representations.

1.1.5 Restrictions on labeling such as organic and eco-friendly

* Where not substantiated by objective evidence, labeling such as organic/eco-friendly is restricted.

### **1.2 Health Functional Food Advertising**

1.2.1 Health functional food means food manufactured/processed using raw materials or ingredients with functionality useful to the human body. Advertising must provide accurate information about the product’s actual functionality and must not mislead consumers or claim therapeutic effects.

1.2.2 Advertising is allowed only where the following are complied with (where prior review is required, supporting evidence is mandatory; advertising differing from the approved content is prohibited).

* United States: The disclaimer must be included (“These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.”)
* Indonesia: Prior approval from the Indonesian Food and Drug Authority (BPOM) is required.
* Thailand: To advertise the efficacy, quality, ingredients, etc. of food, prior approval from the Thai FDA is required.
* China: Advertising is allowed only for products registered with the National Medical Products Administration (NMPA) and that have undergone advertising review by the State Administration for Market Regulation (SAMR). The review number must be stated in the ad creative.
* European Union (EU): Health-function claims not approved by the European Food Safety Authority (EFSA) may not be used in advertising. Claims related to the prevention/treatment of specific diseases are prohibited.
* Australia (AU): Registration and approval from the Therapeutic Goods Administration (TGA) is required, and no efficacy/effects beyond the approved content may be claimed.

1.2.3 All health functional food advertising must comply with the following general principles.

* No therapeutic-effect claims: Claims that a product can diagnose/treat/cure/prevent disease like a pharmaceutical are strictly prohibited.
* No false/exaggerated advertising: Expressions that exaggerate without scientific evidence or that mislead consumers are prohibited (e.g., ‘miracle’, ‘perfect’, ‘in just one day’); advertising beyond the product-label scope is prohibited.
* No misuse of experts: When using recommendations/reviews by medical professionals, ensure authenticity and use only within the scope permitted by the local medical/advertising laws.
* Compliance with government/relevant-department orders: Advertising of a product/content for which a corrective order has been issued must be stopped immediately.

### **1.3 Diet Advertising**

1.3.1 Diet advertising aims to promote weight loss/improvement and a healthy lifestyle and to provide information on related products/services. All advertising must be accurate and ethical and must comply with the laws and regulations of each region.

1.3.2 All advertising must be based on fact and may not contain expressions or images that differ from the facts or excessively exaggerate them so as to deceive/mislead/confuse consumers.

* Hard-to-generalize weight-loss expressions prohibited \[evidence obligation]: Weight-loss figures/effects must be substantiated by the results of human-application trials or clinical trials of an authorized institution and be statistically significant.
* Expressions of efficacy for treating/preventing/suppressing disease prohibited \[compliance with health regulations]: Unless classified as a pharmaceutical, expressions exceeding the health-functional-food efficacy scope recognized by the country’s health authority (e.g., U.S. FDA, France ANSES) are prohibited.
* Expressions that weight loss is possible with the diet product alone are prohibited \[state lifestyle habits]: A balanced diet and regular exercise must be stated as accompanying. Expressions such as ‘sole effect’ or ‘effortless’ are prohibited.
* Unverified facts/deceptive expressions or images prohibited \[state results]: Data/statistics/reviews must be truthful, and the original materials must be retained. Excessive image retouching (Photoshop, etc.) is prohibited.
* Before/after comparison expressions (text/image) for dieting prohibited \[ensure objectivity]: Before/after photo comparisons are prohibited. Instead, objective indicators such as BMI-improvement figures may be presented.
* Otherwise prohibited at the media’s internal discretion \[legal compliance]: Before running, confirm compliance with the latest guidelines of the applicable regional regulator (e.g., North America FTC, France ARPP).

1.3.3 Advertising is prohibited where it contains messages that evoke negative feelings about appearance, create anxiety by imposing particular appearance standards, emphasize unhealthy body images, or induce body shame.

* No creation of shame/anxiety: Expressions that negatively depict a particular body part/size or present unrealistic appearance standards (e.g., ‘Are you beach body ready?’) are entirely prohibited.
* No unhealthy body images: Using excessively thin models, or glorifying abnormally rapid weight loss/harmful diets (e.g., extreme fasting), is prohibited.
* Regional cultural/linguistic considerations — France: Where the model’s body shape (silhouette) in an advertising image has been retouched, comply with the law requiring clear disclosure of the retouching (Loi n° 2016-41) (retouching other than body shape—skin, nose, hair color, etc.—is not subject to this).\\
* LATAM/Southeast Asia (Thailand, Indonesia): Exclude sensitive exposure/expressions in particular cultural/religious contexts and appearance messages that promote social-class discrimination.
* Language: Local-language translations must be professionally reviewed to ensure there are no ambiguous nuances that may deceive/mislead consumers.

### **1.3.4 Minor-targeting restrictions**

Diet-product advertising must restrict targeting in accordance with each country’s minor-protection rules. Where minors cannot be excluded from targeting, the ad may not be run.

* United States: The basis for age restrictions on diet advertising follows the FTC’s deceptive-advertising standards. (For personal-information processing, Common 1.10 and COPPA apply separately.
* EU: Comply with each member state’s minor-protection rules and advertising self-regulation.
* Korea: Comply with the Youth Protection Act.

### **1.4 Medical Advertising**

1.4.1 This provision applies to advertising run by medical institutions/medical corporations/medical personnel; pharmaceutical and medical-device advertising is governed first by 1.5 and 1.6, respectively.

1.4.2 Medical advertising may not be conducted unless by a medical institution/medical corporation/medical personnel formally registered with the competent authority, and the medical institution’s or medical personnel’s name must be stated in the ad creative.

* United States: A state medical license is required.
* EU: Medical-advertising rules differ by country.
* China: Medical-advertising review is required.
* Japan: Compliance with the Ministry of Health, Labour and Welfare’s ‘Medical Advertising Guidelines’ is mandatory. Patients’ subjective testimonials (reviews) and before/after comparison photos are prohibited in principle.

1.4.3 The following content may not be advertised.

* Content that, for profit, introduces/brokers/lures patients to a medical institution/medical personnel
* Content likely to mislead consumers, such as guaranteeing treatment effects
* Content that compares or disparages the functions/treatment methods of other medical institutions/personnel
* Expressions that expose direct procedures such as surgical scenes, or that may evoke disgust/discomfort
* Before/after comparison expressions for procedures and surgery (text/image)
* Use of documents or designs implying abortion is prohibited
* When using patient testimonials — U.S./Australia/U.K.: very strict, comply with FTC/TGA guidance / EU: review use prohibited in some countries
* Other content judged impermissible at the media’s internal discretion
* Telemedicine advertising follows the applicable laws/regulatory standards of the country of running; it may not be run in countries where it is not permitted.

1.4.4 Where a corrective order from the government or relevant agencies has been issued, advertising may be suspended.

### 1.5 Pharmaceuticals and Quasi-drugs Advertising

1.5.1 Prescription drugs or raw-material drugs may not be advertised.

1.5.2 Advertising is allowed only for over-the-counter (OTC) drugs (non-reimbursed drugs purchasable without a prescription) that meet the following conditions.

* The drug to be advertised must be a product approved by the relevant laws and regulatory agency of the country of running.
* Advertising content is allowed only within the approved efficacy/use and scope.
* The advertiser must submit evidence confirming approval upon request.
* Efficacy and major side effects/precautions, etc. must be displayed together in accordance with the fair-balance principle.
* Examples requiring prior approval by country
  * United States: State the FDA-approved use accurately + fair balance (balanced display of efficacy and major side effects).
  * Indonesia: Prior approval from BPOM.
  * Thailand: Prior approval from the TFDA (Thailand FDA).
  * Taiwan: Prior approval from the TFDA (Taiwan FDA) required; only the approved content may be advertised.
  * China: Prior approval from the health authority.
  * France: Prior approval from ANSM (visa GP) required.
  * United Kingdom: Prior authorization from the MHRA required; consistency with prescribing guidance and clear provision of safety information.
  * Japan: Manufacturing/marketing approval under the Pharmaceuticals and Medical Devices Act (PMD Act) is mandatory. Advertising the name/manufacturing method/efficacy/effects of an unapproved drug is absolutely prohibited.

1.5.3 Pharmaceutical advertising may be run only where advertising review under the relevant laws has been obtained, and when using approved ad content, the fact of approval must be displayed within the ad.

1.5.4 Advertising containing the following may not proceed.

* Advertising of abortion-inducing drugs or emergency contraceptives is prohibited.
* Displaying/implying results of use through before-and-after comparison in efficacy/performance advertising is prohibited.
* Displaying disease symptoms/surgical scenes related to efficacy/effects in a threatening manner is prohibited.
* Absolute expressions such as definite guarantee/best/top are prohibited.
* Advertising a drug as if it were not a drug is prohibited.
* Advertising likely to cause a quasi-drug to be mistaken as a pharmaceutical/medical device is prohibited.
* Including content differing from the approved content is prohibited.
* Other content judged impermissible at the media’s internal discretion

1.5.5 Even where a drug is not sold directly, services that influence user choice—such as information provision, comparison, recommendation, or brokerage—may be subject to this provision.

1.5.6 Advertising must comply with the latest laws/regulatory guidance of the relevant country as of the time of running; where standards differ by country, whether to proceed is determined by internal review.

1.5.7 Where the advertising content is unlawful or likely to mislead, ex-post sanctions may follow, and advertising may be suspended upon delivery of a corrective order.

### **1.6 Medical Devices and Health Aids Advertising**

1.6.1 Only medical devices approved by the competent authority may be advertised. They must match the approved use, and advertising of unapproved efficacy/usage is prohibited.

Notes on prior approval

* United States: Prior FDA clearance required.
* Thailand: Advertising allowed only where applicable under the Medical Device Advertising Regulation B.E. 2568 (2025).
* Taiwan: Businesses other than medical-device companies may not advertise medical devices; prior review of ad content is required.
* China: Prior approval of ad content by the health authority is required.
* Japan: Device certification/approval by the Ministry of Health, Labour and Welfare (MHLW)/PMDA is required, and advertising before approval is prohibited.

1.6.2 Advertising containing the following may not be run.

* Content stating that doctors/dentists/oriental-medicine doctors/pharmacists/university professors, etc. designate/certify/recommend/instruct/use it
* Absolute expressions such as definite guarantee/best/top
* Displaying efficacy/effects or related disease symptoms/surgical scenes in a threatening manner
* Medical devices that pose a serious risk to human health
* Including content differing from the approved content
* Other content judged impermissible at the media’s internal discretion

1.6.3 Where a corrective order related to medical devices is issued by the government/relevant department, advertising is not permitted.

1.6.4 Health aids may not run content that causes them to be mistaken as medical devices or that guarantees/overstates efficacy/effects/safety.

1.6.5 Advertising of Veterinary Medical Devices (New)

1.6.5.1 (Definition) A ‘veterinary medical device’ means a medical device intended for exclusive use in animals, and is included within medical devices under the Medical Devices Act (Article 2(1) and Article 46 of the Medical Devices Act).

1.6.5.2 (Requirements for running) Advertising of veterinary medical devices may be run only where all of the requirements below are satisfied. Prior review by the operations team in charge must be obtained before running.

* The product must be licensed by, or notified to, the Animal and Plant Quarantine Agency
* It must be run through the media or means prescribed in Article 44(1) of the Rules on the Handling of Veterinary Drugs, etc.
* The substantive requirements prescribed in Article 24(2) of the Medical Devices Act must be complied with
* Appendix 7 to the Rules on the Handling of Veterinary Drugs, etc. must be complied with

1.6.5.3 (Examples of prohibited expressions) The following are representative examples of prohibited expressions; in addition, all of the running requirements set out in 1.6.5.2 and all statutory compliance requirements apply.

* Advertising of matters other than those officially approved with respect to efficacy or performance
* Advertising liable to create the impression that a veterinarian, animal scientist or the like guarantees, recommends, officially approves, instructs on or acknowledges the performance, efficacy or effect, or is using the product
* Advertising that may cause the product to be mistaken for a medical device for human use, or that states or implies that it may be so used
* Advertising that misrepresents the scale, facilities, awards, track record or the like
* Advertising that misrepresents the raw materials or ingredients
* Advertising of matters concerning quality or efficacy that cannot be, or have not been, objectively verified
* Advertising using exclusive absolute expressions such as “best” or “finest”
* Advertising liable to cause the product to be mistaken for something other than a veterinary medical device
* Advertising that uses users’ letters of appreciation or testimonials, or expressions such as a rush of purchases or orders, or other similar expressions

1.6.5.4 (Offerwall excluded) Because Appendix 7 to the Rules on the Handling of Veterinary Drugs, etc. prohibits advertising by means of providing prizes (prize goods, giveaways, etc.), advertising of veterinary medical devices is not run on Offerwall, which is premised on the payment of rewards.

1.6.5.5 (Running outside Korea) As regulation differs from country to country and medical-device advertising is heavily regulated, expansion to countries other than Korea proceeds only after obtaining advice from local counsel and establishing separate country-specific standards at the time of expansion.

### **1.7 Cosmetics Advertising**

1.7.1 Functional cosmetics mean cosmetics that have the following functions and have passed approval by the review authority (whitening / wrinkle improvement / UV protection).

Review authorities

* Indonesia: Prior review by BPOM is required; for halal products, a halal certificate is required.
* Japan: Expressions exceeding the 56 efficacy/effect categories permitted under the Pharmaceuticals and Medical Devices Act are prohibited, and implying medical efficacy is not allowed.

1.7.2 Advertising containing the following may not be run.

* Content likely to cause it to be mistaken as a pharmaceutical
* Content stating that doctors/dentists/oriental-medicine doctors/pharmacists designate/certify/recommend/use it
* Performance promises referring to permanent changes in the human body
* Other content judged impermissible at the media’s internal discretion

1.7.3 Where a corrective order from the government or relevant agencies is issued, advertising may be suspended.

1.7.4 EU regulations

* Under the EU CPR, comply with completion of the safety assessment, designation of a responsible person within the EU, label compliance, prohibition of false/exaggerated claims, prohibition of consumer confusion, evidence-based advertising, etc.
* Where it cannot be substantiated, expressions such as cruelty-free and vegan are restricted.

### **1.8 Alcohol Advertising**

1.8.1 All alcohol advertising may, in principle, be run only with mandatory adult targeting. The adult-age threshold for each country follows local law (e.g., U.S. 21, Taiwan 18, France 18).

1.8.2 Content selling or delivering alcohol over the internet may not be advertised.

1.8.3 Alcohol ad creative must display the following ‘excessive-drinking warning’.

* United States: GOVERNMENT WARNING: (1) According to the Surgeon General, women should not drink alcoholic beverages during pregnancy because of the risk of birth defects. (2) Consumption of alcoholic beverages impairs your ability to drive a car or operate machinery, and may cause health problems.
* Taiwan: State one of the statutory warnings such as ‘飲酒過量，有害（礙）健康’.
* France: L’abus d’alcool est dangereux pour la santé, à consommer avec modération.

1.8.4 The following may not be advertised.

* Expressions that excessively glorify drinking
* Depictions of drinking while driving/operating machinery
* Depictions of pregnant women/minors as characters or voices
* Other content judged impermissible at the media’s internal discretion

1.8.5 Depending on the ad product/placement/sales method, running may not be possible; prior inquiry/review with the responsible operations team is required before running.

1.8.6 Advertising may be suspended upon delivery of a corrective order, and in some countries alcohol advertising itself is restricted (restricted countries: Indonesia, Thailand, China).

1.8.7 \[Placement restriction] Main premium and fixed placements such as mobile Splash and Special DA are excluded from alcoholic-beverage advertising in view of their reach. Other placements may be used on a limited basis only where the existing conditions (adult targeting, etc.; 1.8.1–1.8.4) are met. (For the operating principles on main premium and fixed placements, see Common Guidelines 2.6.)

### **1.9 Tobacco Advertising**

1.9.1 Advertising of tobacco and related products (including e-cigarettes and heated-tobacco products) may not be run.

1.9.2 Smoking-cessation aids (patches, gum, etc.) are reviewed separately under the pharmaceutical or health-functional-food guide (1.2, 1.5).

1.9.3 Advertising of non-tobacco products of a tobacco brand requires prior review by the operations team.

1.9.4 \[Reaffirmation of the total ban] Regardless of the conditional-permission policies of other media such as NAVER, and regardless of whether it is permitted under the local laws of the country concerned, NAVER WEBTOON entirely prohibits advertising of tobacco and related products in all countries. This includes combustible cigarettes, e-cigarettes (including liquid type), heated-tobacco products, and all e-cigarette devices and device accessories. This standard was shared company-wide by the Sales Policy Notice of 2026.07.16 (including Japan and the United States), and no country-specific exceptions are made. Where a placement operated by an overseas entity or local team is currently run on a conditional-permission basis, it is to be brought into line with this standard.

### **1.10 Gambling, Casino, Horse/Bicycle/Boat Racing, and Lottery Advertising**

1.10.1 Advertising may not be run in accordance with each country’s online-gambling regulations.

1.10.2 \[Clarification of the total ban] All gambling and speculative advertising, including games of chance that are state-authorized or accepted in the local culture, is entirely prohibited regardless of placement. (E.g., Sports Toto and Go-Stop in Korea, boat racing and horse racing in Japan, mahjong in Taiwan.) Where eligibility is ambiguous, the matter is in principle determined to be ineligible to run.

### **1.11 Financial Advertising**

1.11.1 Institutions holding official licenses may advertise the following types (brand advertising for banks, insurers and securities firms; deposit and installment-savings products; insurance; credit cards) — loan products are excluded, and the standards for loans follow 1.11.5.1.

* U.S./U.K./EU: Obligation to display the APR (annual percentage rate) and risk disclosures.
* Detailed standards for credit-card issuance advertising (advertiser qualification, association pre-review, classification by charging method) follow 1.11.7. Issuance-linked (CPA) and reward-on-issuance structures may not be run in Korea (KR); for countries other than Korea, determine according to that country's laws.
* Promotion of loan products and loan-comparison or loan-inducement services may not be run regardless of placement (1.11.5.1). 'Brand advertising' by a financial institution is possible only where it is not intended to promote loan products.
* Savings banks: brand advertising and advertising of deposit-taking products such as deposits and installment savings may be run. However, creative promoting loan products or inducing loans is prohibited under 1.11.5.1, and creative or landing pages that include a path to loan-limit or interest-rate inquiries are likewise prohibited. (For Offerwall, only account-opening and installment-savings products are permitted — see the Financial Advertising section of the 'Offerwall Running Guide'.)

1.11.2 Advertising containing the following may not be run.

* Expressing unconfirmed matters such as interest rates as if they were definite
* Expressing, without basis, a comparative advantage over other financial products
* Expressions that mislead by omitting/minimizing information unfavorable to users or emphasizing only the benefits
* Expressions that distort/exaggerate/omit/obscure matters that materially affect rights/obligations
* Other content judged impermissible at the media’s internal discretion

1.11.3 Clearly explain the product’s risks and returns and clearly express warning statements.

1.11.4 Clearly disclose required information (financial institution name, transaction conditions, interest rate, fees, annual fee, credit-card issuance criteria, etc.).

### **1.11.5 Financial products that may not be advertised**

1.11.5.1 Loans — The following may not be run regardless of placement, including DA, viewer ads, and Offerwall.

* Advertising that promotes loan products themselves (regardless of name: unsecured loans, secured loans, overdraft accounts, cash advances, card loans, revolving credit, emergency-fund loans, etc.)
* Loan comparison, brokerage and recommendation services, and advertising that induces loan-limit or interest-rate inquiries (credit-limit inquiry, rate inquiry, checking the available loan amount, etc.)
* Where the main purpose of the creative or landing page is to induce loan drawdown, application or consultation (the same applies even if it takes the form of financial-institution brand advertising)
* Structures in which loan-related settlement is linked to drawdown or application performance (1.11.7.5 applies mutatis mutandis)
* \[Determination criteria] Regardless of whether the advertiser is a licensed financial institution, the determination is made based on whether the main purpose of the creative and landing page is to promote loan products or induce loans. Where the determination is difficult, do not run the advertisement and check with the policy manager.

1.11.5.2 Other financial products that may not be advertised

* Cryptocurrency — The standard for virtual assets/NFTs follows Common Guidelines 1.6.9 (Integrated standard for virtual assets/NFTs). (In Korea, only brand advertising may be run after prior review; for other countries, check the latest regulations at the time of running: mandatory high-risk warnings, no exaggeration of returns, regulation of influencer marketing.)
* Usurious money lenders
* Private-equity-fund-related products/services
* High-risk financial products
* P2P (peer-to-peer)
* Australia (ASIC): Expressions guaranteeing investment performance are prohibited.
* China: A tendency to prohibit online advertising of high-risk investment products.

1.11.6 Where the advertising content is unlawful or misleading, ex-post sanctions may apply, and advertising may be suspended upon delivery of a corrective order.

### 1.11.7 Credit-Card Issuance Advertising

1.11.7.1 Advertiser qualification: Only a credit-card company licensed for specialized credit finance business, or a credit-card member-solicitation corporation registered with or entrusted by that credit-card company, may be the advertiser for advertising that induces credit-card issuance. Before running, verify the advertiser's qualification through the Financial Supervisory Service's 'registered financial companies' lookup.

1.11.7.2 Pre-review: Credit-card advertising is subject to the Credit Finance Association's voluntary advertising review, so the review result (review number, etc.) must be confirmed from the advertiser before running. The detailed scope of the review subject matter and procedure is to be confirmed against the association's rules.

1.11.7.3 Mandatory creative disclosures: Applying 1.11.4 mutatis mutandis, clearly state the name of the financial institution, the transaction terms, the interest rate, fees, the annual fee, and the credit-card issuance criteria. Definitive statements of interest rates that are not fixed, unsubstantiated claims of comparative superiority, and the omission or minimization of terms unfavorable to users may not be run under 1.11.2.

1.11.7.4 Landing page: The landing page is reviewed separately from creative approval. Where the advertiser is a brokerage-type platform such as a card-comparison or card-recommendation service, it is subject to prior review after a separate qualification check.

1.11.7.5 Classification by charging and settlement method (common to all placements, including DA)

* Impression- or click-based settlement (CPM, CPC, etc.): may be run where 1.11.7.1 through 1.11.7.4 are satisfied
* Issuance-linked settlement (CPA) — \[Korea (KR)] May not be run. To handle credit-card issuance CPA in Korea, a party must hold both registration as a 'financial-product sales agent/broker' under the Financial Consumer Protection Act (the 'credit-card solicitation agency' category of the Credit Finance Association's Financial Product Sales Agent/Broker Certificate) and solicitation qualification under the Specialized Credit Finance Business Act. Credit-card member solicitation may be performed only by the persons listed in Article 14-2(1) of the Specialized Credit Finance Business Act — ① officers and employees of the credit-card company concerned, ② solicitors (persons who broker the conclusion of credit-card issuance contracts on behalf of a credit-card company), and ③ persons who have concluded a business-alliance agreement with a credit-card company on credit-card member solicitation, and their officers and employees (excluding persons whose principal business is solicitation) — and a person who does not fall within these categories and solicits credit-card members is subject to imprisonment for up to one year or a fine of up to KRW 10 million (Article 70(4)2-2 of the same Act). As the media does not hold the above registration or qualification, such advertising is not run in Korea regardless of placement.
* Issuance-linked settlement (CPA) — \[Countries other than Korea] Eligibility to run is determined individually according to that country's laws on financial advertising, card-member solicitation, and sales brokerage. Korea's registration and qualification requirements are not applied as such; before running, confirmation from the organization in charge for that country and from Legal is obtained. Countries for which no confirmation result exists are treated as ineligible to run.
* Structures that pay users economic benefits such as rewards or points conditional on completed issuance — \[Korea (KR)] may not be run regardless of placement. \[Countries other than Korea] determined individually according to that country's card-member solicitation rules and restrictions on providing economic benefits (see 1.11.7.6).

1.11.7.6 Offerwall placements: In Korea (KR), credit-card issuance advertising may not be run (check-card and department-store-card issuance advertising may proceed). For countries other than Korea, eligibility to run is determined country by country according to that country's financial-advertising rules, card-member solicitation rules, and restrictions on providing rewards (economic benefits) conditional on issuance. Detailed standards follow the Financial Advertising section of the 'Offerwall Running Guide'.

1.11.7.7 Effective date: Applies to new campaigns from 2026.08.04. In Korea (KR), issuance-linked (CPA) and reward-on-issuance credit-card campaigns are not accepted; where such a campaign is in progress, termination procedures are carried out after confirmation by the policy manager. For countries other than Korea, the result of the confirmation of that country's laws applies.

### **1.12 Game Advertising**

1.12.1 Advertising of game-item trading and gambling-type games (Go-Stop/poker, etc.) is prohibited.

* Where tangible/intangible rewards are provided for game money through direct/indirect distribution processes, running is prohibited.
* When advertising games containing probability-based items/loot boxes, comply with the relevant country’s laws.

1.12.2 Firearm images in game advertising are allowed only where all of the following are met.

* It is easily recognizable as a game advertisement and is not a photorealistic image that could be mistaken for a real firearm.
* It does not evoke excessive violence/fear, such as firing toward a person.

1.12.3 Games may be advertised only where they have received a game rating. Displaying a rating different from the assigned rating is prohibited; if a rating is falsified/forged, all advertising of that company may be restricted.

1.12.4 Advertising may be suspended upon delivery of a corrective order. ESRB/PEGI rating labeling is mandatory in the EU/China/U.S.

### **1.13 Chat and Adult/Semi-adult Advertising**

1.13.1 A semi-adult site means a site that holds both general content and adult content.

1.13.2 Chat and adult/semi-adult sites may not be advertised.

### **1.14 Election/Political Party Advertising**

1.14.1 Not permitted, for political neutrality and user protection.

### **1.15 Education/Academy/Employment Advertising**

1.15.1 Only institutions officially licensed by each country’s Ministry of Education/education office, etc. may be advertised.

* Institutions subject to licensing (academies/schools, etc.) must submit proof of licensing by the relevant country’s education authority.
* Services not subject to licensing (apps/platforms, etc.) are determined after prior review by the operations team according to their nature.

1.15.2 Advertising containing the following may not proceed.

* Failure to provide prior information (program name/content, period/schedule, tuition, whether employment support is provided, etc.)
* Including content harmful to youths’ physical/mental health
* Other cases judged impermissible at the media’s internal discretion

### **1.16 Opinion Advertising**

1.16.1 Opinion advertising that presents opinions about a specific person or opposes a specific person/group may not be run.

1.16.2 Opinion advertising that one-sidedly asserts/explains events with potential for social issues/disputes may not be run.

1.16.3 One-sided opinions/assertions/explanations regarding matters under litigation/dispute through state agencies/local governments, etc. may be restricted.

1.16.4 When using another person’s review, evidence and the fact that it is an intentional staging must be disclosed.

1.16.5 Other cases judged impermissible at the media’s internal discretion may be restricted.

### **1.17 Fashion/Household Goods**

1.17.1 Advertising of related products/content such as ‘sex-related functional underwear, sexy underwear’ is prohibited.

1.17.2 Advertising of sexually suggestive or discomforting images/expressions of underwear (including similar products) is prohibited.

1.17.3 Advertising of content that may cause shame/excessive discomfort regarding women’s household goods is prohibited.

1.17.4 Other cases judged impermissible at the media’s internal discretion may be restricted (cultural norms such as sexual-content standards, cultural sensitivity, and religious/racial sensitivity must be considered).

### **1.18 Prohibition of Inappropriate Content**

1.18.1 Dangerous or derogatory content (demeaning a specific race/religion/gender or inciting violence)

1.18.2 Shocking content (images causing excessive anxiety, such as physical injuries/accident scenes)

### **1.18.3 Animal abuse**

1.18.4 Adult content (pornography, non-consensual sexual content, child sexual abuse images, adult products, sexually suggestive content, excessive nudity, and other content impermissible at internal discretion)

### **1.19 Other Prohibited Industries Not Classified by Industry Code**

1.19.1 Religious advertising may not be run.

1.19.2 Illegal-loan advertising such as ‘card discounting’/‘phone discounting’ may not be run.

1.19.3 Certain financial industries and business types posing a risk of user harm may not be run (including promotion of loan products, loan-comparison and loan-inducement services, usurious lending, and unregistered loan brokerage. Detailed standards follow 1.11.5.1.)

1.19.4 Advertising of illegal products whose distribution/sale/import is prohibited is not permitted.

1.19.5 Advertising of IP-infringing products (counterfeit goods/illegal copies) is prohibited.

1.19.6 Advertising of narcotics and psychotropic drugs is prohibited.

1.19.7 Advertising of weapons is prohibited.

1.19.8 Advertising of detective/errand agencies is prohibited.

1.19.9 Multi-level (pyramid) advertising is prohibited.

1.19.10 Advertising of tattoo procedures and related education/information provision is prohibited.

1.19.11 Advertising of fortune-telling/horoscope services is prohibited.

1.19.12 P2E, NFT games, and other cashable games and game-item trading (including games with prize/cash-equivalent rewards)

1.19.13 Other country-specific prohibited industries — Taiwan: advertising of mainland-China OTT platforms

\* Note: Streaming services whose primary business is the viewing or subscription of short-form drama (micro-drama) video may not be run regardless of country under Common Guidelines 1.9.5 (designation as a competitor); in the case of Taiwan, this 1.19.13 may apply in addition where the operator of the service is a mainland-China business. (The operator and the location of the corporate entity are to be confirmed individually at the time of the running review.)

1.19.14 Other cases judged impermissible at the media’s internal discretion may not be run.

The country-specific regulatory information stated in this document is as of the last-updated date and may change thereafter. Before running an ad, be sure to check the latest laws of the relevant country.
{% endtab %}
{% endtabs %}

{% hint style="success" %}
For any questions or advertising inquiries, please use the [**Contact Us** ](https://advertising.webtoon.com/en/contact-us)form.
{% endhint %}


---

# Agent Instructions
This documentation is published with GitBook. GitBook is the documentation platform designed so that both humans and AI agents can read, navigate, and reason over technical content effectively. Learn more at gitbook.com.

## Querying This Documentation
If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question.

Perform an HTTP GET request on the current page URL with the `ask` query parameter, and the optional `goal` query parameter:

```
GET https://guides.advertising.webtoon.com/ad-policies/guidelines-by-industry.md?ask=<question>&goal=<endgoal>
```

`ask` is the immediate question: it should be specific, self-contained, and written in natural language.
`goal` is optional and describes the broader end goal you are ultimately trying to accomplish on behalf of the user. GitBook uses it to tailor the answer towards what is most useful for that goal.

The response will contain a direct answer to the question and relevant excerpts and sources from the documentation.

Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.